In spite of warning: heart patients Diclofenac get too often
Taking the prescription pain reliever Diclofenac can also increase in some individuals the risk for heart attacks and strokes significantly. Six years ago, there was an official warning. Nevertheless, many high-risk patients continue to receive the painkillers. The fact, researchers at the Leibniz Institute for prevention research and epidemiology (BIPS) point.
In 2013, a warning went out to the German medical Profession, that the active substance Diclofenac should not be prescribed for certain groups of patients. For this purpose, patients with heart failure, ischemic heart disease, or diseases that affect the blood vessels of the brain count. A new study shows that this has not led, however, Doctors prescribe such high-risk patients less Diclofenac. The GDP researchers report, according to an analysis of health insurance data for the regulation of Diclofenac, the results of which are published in the Journal of Internal Medicine (JIM).
High-risk patients continue to get Diclofenac
Although it showed that 2014 was prescribed compared to 2011 in absolute terms, significantly less Diclofenac for the first time. So in 2014, received by the more than 10 million persons examined, 30 percent less for the first time, Diclofenac than in 2011. However, 12 percent of persons at-risk patients &ndash were still; just as many as in 2011. "The decrease of the Diclofenac-regulations, therefore, seems to be a General Trend have been and. to the risk groups in the Special ausgewirkt"…, Oliver plaice, study first author from the GDP says.
Aufkläinnovation in physician practices is necessary
"You have to assume that it came from seizures due to these regulations, to heart attacks and strokes that could have been avoided, because there are safer Alternatives to Diclofenac", Prof. Dr. Ulrike Haug, last author of the study and head of the Department of Clinical epidemiology at BIPS added. More information in medical practices to the risks of Diclofenac – also in the case of short-term ingestion and lower dose – be Haug, according to urgent need.
GDP/NK